Ligand validation:4XVU

ATP: ADENOSINE-5'-TRIPHOSPHATE

ATP is a Ligand Of Interest in 4XVU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XVU_ATP_A_401	80%	12%	0.13	0.978	2.28	1.79	10	7	0	0	100%	1
4XVU_ATP_H_401	77%	12%	0.134	0.975	2.28	1.75	9	6	0	0	100%	1
4XVU_ATP_G_401	73%	11%	0.139	0.968	2.31	1.88	9	8	0	0	100%	1
4XVU_ATP_B_401	72%	11%	0.144	0.968	2.25	1.89	9	7	0	0	100%	1
4XWO_ATP_G_404	92%	13%	0.07	0.962	2.43	1.53	11	6	1	0	100%	0.55
4XTR_ATP_A_404	72%	11%	0.141	0.964	2.3	1.86	10	9	0	0	100%	0.62
7QDX_ATP_B_603	100%	66%	0.022	0.997	0.52	0.8	-	2	2	0	100%	1
9KQD_ATP_J_301	100%	58%	0.024	0.995	0.8	0.8	-	1	0	0	100%	1
2PNN_ATP_A_374	100%	30%	0.027	0.995	1.34	1.43	4	5	2	0	100%	0.98
5J1T_ATP_A_401	100%	31%	0.03	0.994	1.31	1.43	2	7	0	0	100%	1
9KQ7_ATP_K_301	100%	59%	0.029	0.991	0.73	0.84	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.